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Thymically derived Foxp3+ regulatory T (Treg) cells
have a propensity to recognize self-peptide:MHC
complexes, but their ability to respond to epitope-
defined foreign antigens during infectious challenge
has not been demonstrated. Here we show that pul-
monary infection with Mycobacterium tuberculosis
(Mtb), but not Listeria monocytogenes (Lm), induced
robust lymph node expansion of a highly activated
population of pathogen-specific Treg cells from the
pre-existing pool of thymically derived Treg cells.
These antigen-specific Treg cells peaked in numbers
3 weeks after infection but subsequently underwent
selective elimination driven, in part, by interleukin-
12-induced intrinsic expression of the Th1-cell-pro-
moting transcription factor T-bet. Thus, the initial
Mtb-induced inflammatory response promotes path-
ogen-specific Treg cell proliferation, but these cells
are actively culled later, probably to prevent suppres-
sion during later stages of infection. These findings
have important implications for the prevention and
treatment of tuberculosis and other chronic diseases
inwhich antigen-specific Treg cells restrict immunity.
INTRODUCTION
Regulatory T (Treg) cells, a subset of CD4+ T cells characterized
by their stable expression of the transcription factor Foxp3, pre-
vent autoimmune disease (Sakaguchi et al., 2008) but can also
restrict immunity to infectious microbes (Belkaid and Tarbell,
2009). During infections, Treg cells appear to play a dichotomous
role: on the one hand, they benefit the host by curbing excessive
inflammation that could be deleterious to host tissues (Belkaid
and Tarbell, 2009). On the other hand, by limiting potentially pro-
tective immune responses, they can facilitate pathogen replica-tion and persistence, as shown for several chronic infections,
including tuberculosis (Belkaid and Tarbell, 2009; Kursar et al.,
2007; Scott-Browne et al., 2007). Strategic manipulations of
Treg cells that promote pathogen clearance while avoiding detri-
mental consequences to the host could provide new avenues to
prevent or treat persistent infections. One approach would be to
exploit their microbial antigen specificity, because T-cell-recep-
tor (TCR)-mediated signals are required for their suppressive
function (Sakaguchi et al., 2008), but the specific antigens recog-
nized by Treg cells during infection are largely unknown, and in
most cases it is not even clear whether Treg cells recognize
microbe-derived antigens or primarily respond to self-antigens.
A fundamental question in immunology, one that also raises
practical considerations that impact protective immunity and
vaccination, is whether thymically derived Treg cells can
respond to microbe-derived antigens during infection. During
homeostatic conditions, commensal biota-specific Treg cells
accumulate in the gut-associated lymphoid system. Some
studies suggest that these cells are peripherally induced Treg
cells (Atarashi et al., 2011; Lathrop et al., 2011; Round and Maz-
manian, 2010), although a recent study suggests that they are
thymically derived Treg cells (Cebula et al., 2013). During chronic
lymphocytic choriomeningitis virus (LCMV) infection, Treg cells
have been shown to recognize a self-antigen rather than a
virus-specific antigen (Punkosdy et al., 2011). This finding may
reflect the fact that thymically derived Treg cells are selected
by high-affinity interactions with self-antigens within the thymus
(Bautista et al., 2009; DiPaolo and Shevach, 2009) and therefore
have a propensity for recognizing self-antigens in the periphery
(Hsieh et al., 2004, 2006; Killebrew et al., 2011; Korn et al.,
2007). Nonetheless, thymically derived Treg cells specific for
foreign epitopes have been detected in the naive population
(Ertelt et al., 2009; Moon et al., 2011; Zhao et al., 2011), but their
expansion during infection has not been shown.
Multiple studies with different infectious models have failed to
definitively identify microbe-specific thymically derived Treg
cells (Ertelt et al., 2009; Antunes et al., 2008). For Salmonella (Jo-
hanns et al., 2010) and neurotropic mouse hepatitis virus (Zhao
et al., 2011) infections, low frequencies of microbe-specificImmunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc. 1261
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Figure 1. Detection of ESAT-64-17-Specific Treg Cells in the pLNs of
Mtb-Infected Mice
(A) Gating strategy used to identify CD3+CD4+ESAT-64-17-specific cells in the
pLNs of B6mice, 21 days after aerosol infection. PLNs from threeMtb-infected
mice or all lymph nodes from an uninfected control mouse were pooled and
enriched for ESAT-64-17-specific cells.
(B) Binding of tetramer and expression of Foxp3 by CD4+ cells within pLN cells
(day 21 after infection) after enrichment of tetramer-binding cells. The per-
centage of tetramer-binding cells expressing Foxp3 is shown. Histograms
denote the amount of Foxp3 expression in tetramer-binding Treg cells (red),
non-tetramer-binding Treg cells (blue), and Foxp3CD4+ T cells (solid gray) in
the pLN. Graph depicts mean fluorescent intensity (MFI) of Foxp3 within each
of these three populations. Cumulative data from six independent experiments
are shown. MFI values are normalized to those obtained for tetramer-binding
Treg cells. Each solid square, triangle, or circle represents an experiment and
the bars represent the mean of the six experiments performed. See also
Figure S1.
Immunity
Mtb-Specific Thymically Derived Treg CellsFoxp3+CD4+ T cells have been reported; however, whether
these populations represented thymically derived or peripherally
induced Treg cells was not clear. During Leishmania infection,
thymically derived Treg cells were shown to proliferate specif-
ically to Leishmania-infected dendritic cells, suggesting that
they recognized a microbe-derived antigen (Suffia et al., 2006),
and similar results were recently reported showing specific pro-
liferation of Treg cells from influenza-infected mice after stimula-
tion with influenza-infected dendritic cells (Betts et al., 2012). In
both cases, however, the specificity of these expanded Treg
cells were not identified, leaving the possibility that infection of
dendritic cells induced the expression of novel self-proteins
that were the actual target of Treg cell recognition. Finally, after
Mycobacterium tuberculosis (Mtb) infection, we showed that
pathogen-specific Treg cells from TCR transgenic mice, but
not Treg cells with irrelevant specificities, proliferate robustly in
infected mice (Shafiani et al., 2010). However, Mtb specificity
was not directly demonstrated among the endogenous Treg
cell population. Thus, the question of whether endogenous
Treg cells from the thymically derived Treg cell pool recognize
microbe-derived antigens during responses to infectious chal-
lenge remains unanswered.
In this study, we found that early after Mtb infection, a substan-
tial fraction of the CD4+ T cells in the pulmonary lymph node
(pLN) recognizing an immunodominant Mtb epitope expressed
high amounts of Foxp3 and markers of Treg cell activation.
These cells arose from the thymically derived Treg cell popula-
tion in a context-dependent manner; pulmonary infection with
recombinant Listeria monocytogenes (Lm) expressing the
same Mtb-derived epitope resulted in pLN expansion of anti-
gen-specific effector T cells but not Treg cells. The Mtb-specific
Treg cells peaked in numbers 3 weeks after infection and
declined thereafter, a process driven in part by interleukin-12
(IL-12)-induced T-bet expression. Our results suggest a model
in which Mtb-induced inflammation promotes proliferation of
pathogen-specific Treg cells when adaptive immunity is initiated,
but the subsequent host response selectively culls these highly
suppressive Treg cells so that they cannot restrict immunity
during later stages of infection.
RESULTS
Mtb-Specific Treg Cells Expand in the pLNs of
Infected Mice
First we sought to determine whether Mtb-specific Foxp3+ cells
were present within endogenous CD4+ T cell populations in mice
infected with a low dose of aerosolized Mtb. Because we previ-
ously showed that transfer of small numbers of transgenic Mtb-
specific Treg cells impaired immunity by restricting priming of
effector T cells in the pLN (Shafiani et al., 2010), we focused on
the pLN during early infection. To overcome the fact that Mtb-
specific CD4+ T cells comprise only a small population in the
pLN (Figure S1A available online), we employed a tetramer-
based approach to enrich rare populations of antigen-specific
T cells (Moon et al., 2007, 2009). Pulmonary LN cells from multi-
ple Mtb-infected mice on day 21 after infection were pooled,
enriched for ESAT-64-17:I-A
b tetramer-binding cells with mag-
netic beads and columns, stained for cell surface markers, and
permeabilized for subsequent intracellular Foxp3 staining.1262 Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc.Although some cells bound the magnetized column nonspecifi-
cally, a large population of CD44hi tetramer-binding CD4+
T cells was found after first gating on CD3+ cells and excluding
non-T cell lineage cells from the analysis (Figure 1A). This popu-
lation was not observed in uninfected mice or within CD8-gated
T cells from infected mice (Figure 1A). A defined population of
tetramer-binding CD4+ T cells in the pLN on day 21 after infection
was consistently observed to express Foxp3 (usually 5%–20%
of the tetramer-binding CD4+ T cells), and these Mtb-specific
Treg cells expressed higher amounts of Foxp3 than did non-
tetramer-binding Treg cells in the same lymph node (Figure 1B).
These findings were not unique to this antigen because Foxp3+
CD4+ T cells with specificity for the Mtb epitope Ag85B240-254I-
Ab were also observed, albeit at a slightly lower frequency (Fig-
ure S1B). Thus, Foxp3-expressing Treg and effector T cells
recognizing the same immunodominant Mtb epitopes both un-
dergo robust expansion in the pLN after aerosolized infection.
Mtb-Specific Treg Cells Are Activated but Do Not
Produce IFN-g
We next assessed tetramer-binding CD4+Foxp3+ T cells in the
pLN for cell surface and intracellular molecules characteristic
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Figure 2. ESAT-64-17-Specific Treg Cells
Express an Activated Phenotype
(A) Expression of the indicated activation mole-
cules by CD4+Foxp3+ cells that either bind (red) or
do not bind (blue) the tetramer or by CD4+Foxp3
cells that either bind (black) or do not bind (solid
gray) the tetramer in the pLN of Mtb-infectedmice,
21 days after infection. Data are representative of
three independent experiments.
(B) ESAT-64-17-specific cells among CD4
+
tetramer-enriched pLNs were gated for subse-
quent analysis of IFN-g production (left). Middle
panels depict direct ex vivo detection of intracel-
lular IFN-g by Foxp3-expressing or Foxp3 cells
21 days after infection. Staining with an isotype
antibody of irrelevant specificity (clone MOPC-21)
was used as negative control. Numbers represent
the percentage of tetramer-binding Foxp3 or
Foxp3+ cells producing IFN-g in this representative experiment. Cumulative data from four independent experiments are also shown; each circle or triangle
represents the percentage of IFN-g within the indicated population. Each solid circle or triangle represents an experiment and the bars represent the mean of
the four experiments performed.
See also Figure S2.
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Mtb-Specific Thymically Derived Treg Cellsof Treg cells and their activation. Consistent with their identity
as bona fide Treg cells, tetramer-binding Foxp3+ cells ex-
pressed high amounts of cell surface CD25, CTLA-4, GITR,
CD103, and ICOS (Figure 2A, red histograms), compared to
Foxp3-negative CD4+ T cells in the pLN that either did or did
not bind the tetramer (Figure 2A, black and gray histograms,
respectively). However, these antigen-specific Treg cells ex-
pressed less CD25 but higher amounts of CTLA-4, GITR,
CD103, and ICOS than other Treg cells in the pLN that did not
bind the tetramer (Figure 2A, blue histograms). Mtb-specific
tetramer-binding Treg cells also expressed T-bet at only slightly
lower levels than those observed in tetramer-binding effector
T cells (Figure 2A). Thus, Treg cells recognizing Mtb antigens
exhibit a more activated phenotype than other Treg cells in the
same lymph node.
Because T-bet expression is strongly associated with IFN-g
production (Glimcher, 2007), we next asked whether T-bet-
expressing Mtb-specific Treg cells produced IFN-g in vivo.
Tetramer-binding CD4+ T cells were analyzed directly ex vivo
(without in vitro restimulation) for intracellular IFN-g after har-
vesting pLN of Mtb-infected mice in the presence of a Golgi-
mediated transport inhibitor (brefeldin A). For comparison we
assessed effector T cells and consistently observed a popula-
tion of tetramer-binding Foxp3-negative CD4+ T cells producing
IFN-g with no observed staining by using an isotype-matched
control antibody (Figure 2B). At day 21 after infection, 5% of
these effector CD4+ T cells were producing IFN-g, and at day
25 this frequency increased to 14% (Figure S2). In contrast,
we did not observe IFN-g production at any time in tetramer-
binding Foxp3+ cells (Figures 2B and S2). These results are
consistent with our previous findings that Treg cells from
Mtb-infected mice do not produce IFN-g even after polyclonal
stimulation in vitro (Scott-Browne et al., 2007) and support
the idea that in contrast to the plasticity of Treg cells recently
described in parasitic and viral infections (Oldenhove et al.,
2009; Zhao et al., 2011), Treg cells do not produce IFN-g during
tuberculosis despite expressing high levels of T-bet (Koch
et al., 2012).Mtb-Specific Foxp3+CD4+ T Cells Arise from the
Thymically Derived Treg Cell Lineage
We next investigated the origin of expanded Mtb-specific Treg
cells to determine whether they arise from the thymically derived
or the peripherally induced Treg cell populations. Initially, the
TCR usage of tetramer-binding Foxp3 and Foxp3+CD4+
T cells specific for the same Mtb epitope were characterized
because a previous report showed that a subset of the ESAT-
6-specific effector CD4+ T cells in Mtb-infected C57BL/6 mice
express TCRs containing Vb6 (Winslow et al., 2003). Consistent
with these results, we observed an expanded population of
Vb6+CD4+ T cells within the Foxp3, but not within the Foxp3+,
tetramer-binding population (Figure 3A). These findings indicate
that tetramer-binding Foxp3-negative and Foxp3+CD4+ T cells
do not have identical TCR repertoires, and suggest they do not
originate from the same precursor population.
We next assessed intracellular expression of Helios, a tran-
scription factor reported to be highly expressed by thymically
derived Treg cells but not peripherally induced Treg cells (Thorn-
ton et al., 2010). Helios was highly expressed in the majority of
tetramer-binding Foxp3+CD4+ T cells (Figure 3B), whereas other
pLN Treg cells showed a distribution of Helioshi and Helioslo cells
consistent with published data (Thornton et al., 2010). These
results support the idea that Mtb-specific Treg cells expand
from the thymically derived Treg cell population.
Finally, we cotransferred congenically marked CD4+Foxp3
(CD45.2) and Foxp3+ (CD45.1) T cells from Foxp3-GFP reporter
mice (Fontenot et al., 2005) into T cell-deficient (Tcra/Tcrd/)
recipients and infected them with Mtb on the following day.
ESAT-64-17:I-A
b-specific T cells were enriched from the pLN on
day 21 after infection and Foxp3 expression was assessed in
each congenically marked population (Figure 3C). The popula-
tion initially transferred as Foxp3 cells gave rise only to
tetramer-binding Foxp3CD4+ T cells. In contrast, the Foxp3+
transferred cells gave rise to a population of tetramer-binding
CD4+ T cells that continued to express Foxp3, directly indicating
that Mtb-specific Treg cells expand from the pool of Foxp3+
CD4+ T cells present before infection (Figure 3C). Moreover,Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc. 1263
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Figure 3. ESAT-64-17-Specific Treg Cells
Arise from Pre-existing Foxp3+ Precursors
(A) Gated on ESAT-64-17-specific CD4
+ T cells
(left), the expression of Foxp3 and Vb6 is shown in
the tetramer-enriched pLN of mice 21 days after
infection. Numbers represent the percentage of
cells within each quadrant. Cumulative data from
three independent experiments are also shown;
each symbol represents the percentage of Vb6+
T cells within the indicated population. Each solid
triangle or circle represents an experiment and the
bars represent the mean of the three experiments
performed.
(B) Expression of Foxp3 and Helios is shown gated
onnon-tetramer-bindingFoxp3+CD4+Tcells or the
tetramer-binding Foxp3+ T cells from the enriched
pLN on day 21 after infection. Numbers represent
the percentage of cells in the quadrant. Cumulative
data from three independent experiments show
relativeHelios expression by non-tetramer-binding
Foxp3 cells, non-tetramer-binding Foxp3+ cells,
and tetramer-binding Foxp3+ cells within the CD4-
gated population of the same pLN. Because of
variability in the MFI of Helios expression between
individual experiments, values are normalized to
those obtained for tetramer-binding Foxp3+ cells.
Each solid square, triangle, or circle represents an
experiment and the bars represent the mean of the
three experiments performed.
(C) CD45.2 and CD45.1 expression on CD4-gated
T cells from tetramer-enriched pLN of T cell re-
constituted Tcrb/ Tcrd/ mice on day 21 after
infection. Foxp3-GFP expression and ESAT-
64-17:I-A
b tetramer binding is shown for cells
transferred as either Foxp3 precursors (CD45.2,
blue gate) or Foxp3+ precursors (CD45.1, red
gate). Numbers represent the percentage of cells
within each quadrant. The experiment was per-
formed twice and representative data are shown.
See also Figure S3.
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Mtb-Specific Thymically Derived Treg CellsESAT-64-17:I-A
b-specific Treg cells were observed in the pLN of
Mtb-infected Tcra+/ mice (Figure S3), excluding the possibility
that Treg cells recognizing this epitope were selected in the
thymus by an alternative TCRwith a different TCRa chain. Taken
together, the results suggest that Mtb-specific Treg cells expand
from the thymically derived Treg cell lineage.
Proliferation of Antigen-Specific Treg Cells Is Context
Dependent
To investigate whether expansion of ESAT-64-17:I-A
b-specific
Treg cells could reflect either unique properties of the ESAT-6
epitope or alternatively the lung tissue environment, we gener-
ated a recombinant strain of Lm expressing the ESAT-6 epitope
(Lm-ESAT-6) and infected mice intranasally to establish a suble-
thal pulmonary infection. Although ESAT-64-17:I-A
b-specific
effector T cells were readily detected in the pLN of Lm-ESAT-
6-infected mice beginning on day 5 after infection, tetramer-
binding Foxp3+ cells were not observed at any time during the
infection, which is cleared between days 8 and 10 (Figure 4
and data not shown). In addition, only small numbers of Treg1264 Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc.cells specific for an endogenous Lm antigen were observed (Fig-
ure S4). Thus, the finding that Mtb induces a sizeable population
of microbe-specific thymically derived Treg cells cannot be ex-
plained by inherent properties of the ESAT-6 antigen itself, or pri-
mary infection within the lung, but instead suggests that Mtb
selectively induces an inflammatory milieu that is conducive to
the expansion of antigen-specific thymically derived Treg cells.
Mtb-Specific Treg Cells Undergo Subsequent
Contraction
We next monitored the location and abundance of antigen-spe-
cific Treg cells throughout the course of Mtb infection, focusing
on the pLN and lung (the primary site of infection). In the pLN, the
percentage of tetramer-binding CD4+ T cells that expressed
Foxp3was highest early after infection, up to 20% (150–300 cells
per lymph node) at day 20 (Figure 5). By day 32 after infection,
this percentage fell to less than 5% (5–35 cells), and tetramer-
binding Treg cells were only inconsistently detected at these
later time points. In the lung, however, there was a relative
paucity of tetramer-binding Treg cells at any time point. In
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Figure 4. Expansion of ESAT-64-17-Specific Treg Cells Is Context
Dependent
(A) Foxp3 expression and ESAT-64-17:I-A
b tetramer binding within CD4-gated
tetramer-enriched pLN of Mtb-infected or Lm-ESAT-6-infected mice at day 21
or day 9 after infection, respectively. Pooled pLNs from each group were en-
riched for tetramer-binding cells, and the experiment was performed six times
for Mtb and three times for Lm-ESAT-6. Numbers represent the percentage of
tetramer-binding T cells that express Foxp3.
(B) Cumulative data from six experiments with Mtb-infected and three ex-
periments with Lm-ESAT-6-infected mice are shown. Each circle or triangle
represents a time point.
See also Figure S4.
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Figure 5. Mtb-Specific Treg Cells Exhibit Early but Short-Lived
Accumulation in the pLN
Mtb-infected mice were sacrificed at the indicated time points after infection,
and cells from their lungs and tetramer-enriched pLNs were analyzed for
tetramer binding and Foxp3 expression. Numbers in the quadrants represent
the percentage of tetramer-binding cells that express Foxp3. Experiments
were performed ten times at day 20 or 21, six times at day 32–35, and twice at
each later time point.
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Mtb-Specific Thymically Derived Treg Cellssome experiments, up to 5% of tetramer-binding CD4+ T cells
expressed Foxp3 at day 20, but very few, if any, of these cells
could be detected later (Figure 5). Thus, Mtb-specific Treg
cells undergo initial expansion in the pLN during the period
when rapid priming and expansion of Mtb-specific effector
T cells is critical to establish early control of infection (Cooper,
2009; Shafiani et al., 2010; Urdahl et al., 2011). However, these
cells are short lived and do not accumulate in the lung.
IL-12-Induced Intrinsic T-bet Expression Drives
Mtb-Specific Treg Cell Contraction
We next asked whether contraction of Mtb-specific Treg cells
could be due to the lack of available IL-2, a cytokine that drives
Treg cell proliferation and survival (Cheng et al., 2011). We
administered IL-2 plus IL-2 antibody complexes to Mtb-infected
mice during the peak of the antigen-specific Treg cell response.
Although we observed expansion of Treg cells with other speci-
ficities in the pLN, the Mtb-specific Treg cells still underwent
contraction (Figure S5). These results are consistent with our
observation that Mtb-specific Treg cells express lower amounts
of CD25 than do other Treg cells in the pLN (Figure 2A) and sug-
gest that contraction is not the result of IL-2 deprivation.
To investigate the possibility that other inflammatory cytokines
drive the disappearance of Mtb-specific Treg cells, we infected
mice deficient in either IFN-a/b receptor (Ifnar/) or the cyto-
kines IL-6 (Il6/), IL-12p35 (Il12a/), and IL-12p40 (Il12b/),
which are known to participate in the inflammatory response to
Mtb infection (Cooper et al., 2011). The contraction tempo of
Mtb-specific Treg cells in mice lacking either the IFN-a/b recep-
tor or IL-6 was comparable to WT controls (Figure S6A). By
contrast, Mtb-specific Treg cells did not appear to undergo
contraction in IL-12p35-deficient mice; they were observed in
similar numbers at days 21 and 35 after infection (Figures 6A
and 6B). In IL-12p40-deficient mice, not only did Mtb-specific
Treg cells persist, but they continued to expand from day 21
through day 35 in the pLN and were also observed in the lungs
(Figure S6). The lack of Treg cell contraction in IL-12-deficient
mice could not be explained by increased bacterial and antigenicload because IFN-g-deficient mice had similar or even higher
bacterial burdens in their lungs and pLN (Figure 6C) but exhibited
contraction of Treg cells similar to WT mice. These results sug-
gest that IL-12 (p40:p35 heterodimer) is essential for Mtb-
specific Treg cell contraction and that the p40 molecule further
impedes the continued expansion of these cells in an IL-12-inde-
pendent manner.
T-bet expressionwas 2-fold higher inMtb-specific Treg cells in
WT mice compared to mice lacking IL-12 (MFI values of 2,430
and 1,330, respectively; data not shown), an observation consis-
tent with the finding that IL-12 is required for high T-bet expres-
sion in Treg cells (Koch et al., 2012). Because T-bet can exhibit
proapoptotic properties in some settings (Joshi et al., 2007; Old-
enhove et al., 2009), the dynamics ofMtb-specific Treg cellswere
examined in mice lacking T-bet specifically in Foxp3+ Treg cells
(Tbx21fl/fl:Foxp3-IRES-Cre mice) (Intlekofer et al., 2008; Wing
et al., 2008). We found that Mtb-specific Treg cells with a tar-
geted deficiency in T-bet persisted until day 35 after infection,
directly paralleling the response in IL-12p35-deficient mice
(Figures 6D–6F). Taken together, these findings demonstrate
that IL-12-induced T-bet expression drives the contraction of
pathogen-specific Treg cells during persistent Mtb infection.
DISCUSSION
Here we show that antigen-specific thymically derived Treg
cells, defined to the epitope level, can expand to a foreign
antigen during infection. This finding is supported by three lines
of evidence. (1) Conventional and Treg cells recognizing the
same Mtb epitope (i.e., ESAT-64-17:I-A
b) utilized discordant
TCR repertoires, suggesting that they arose from separate line-
ages. (2) ESAT-64-17:I-A
b-specific Treg cells expressed high
amounts of Helios, a transcription factor associated with thymi-
cally derived Treg cells (Thornton et al., 2010). (3) Reconstitution
studies demonstrated that ESAT-64-17:I-A
b-specific Treg cells
expanded from the pre-existing pool of Foxp3+ T cells present
in uninfected mice.Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc. 1265
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Figure 6. Mtb-Specific Treg Cell Contrac-
tion Is Driven by IL-12-Induced T-bet
Expression
(A) FACS plots represent column-enriched pLNs
from Mtb-infected control wild-type (WT) B6 mice
and mice deficient in IL-12p35 (Il12a/), IL-12p40
(Il12b/), and IFN-g (Ifng/) analyzed for
tetramer binding cells and Foxp3 expression. Mice
were harvested at day 21 and 35 after infection
with the exception of IFN-g-deficient mice that
were analyzed at day 32 because they had lost
20% of their body weight and appeared near
death. Numbers in the quadrants represent the
percentage of Foxp3+ cells within the tetramer-
binding population. Experiments were performed
four times for the WT and Il12b/ mice, twice for
Ifng/ mice, and once for the Il12a/ mice.
Representative plots are shown.
(B) Bar graphs represent absolute number of
tetramer-binding Treg cells at the two time points
in all the above groups. Mean ± SEM is shown for
the WT and Il12b/ groups.
(C) Mtb CFUs in the lungs and pulmonary lymph
nodes of the four groups of mice at the two
time points are depicted (ND, not determined).
Each solid circle, square, or triangle represents a
mouse and the bar represents the mean of the
group.
(D) FACS plots represent column-enriched pLNs
from Mtb-infected control Foxp3-IRES-Cre mice
(FIC), and mice with conditional deficiency of
T-bet expression in Foxp3-expressing Treg cells
(Tbx21fl/fl:FIC), analyzed for tetramer-binding cells
and Foxp3 expression. Mice were harvested at
day 21 and 35 after infection. Numbers in the
quadrants represent the percentage of Foxp3+
cells within the tetramer-binding population.
Experiments were performed once for each time
point.
(E) Bar graphs represent absolute number of
tetramer- binding Treg cells at the two time points
in both groups.
(F) Histograms denote the levels of T-bet expres-
sion in tetramer-binding Treg cells in either control
FIC mice (red) or Tbx21fl/fl-FIC (purple) and
CD44Foxp3CD4+ T cells (solid gray) in the pLN
at day 21 after infection.
See also Figure S6.
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Mtb-Specific Thymically Derived Treg CellsMtb-specific Treg cells exhibited a highly activated phenotype
with increased Foxp3, Helios, CTLA-4, GITR, CD103, and ICOS
expression compared with other Treg cells in the pLN. These
results suggest that antigen recognition is critical and that
Treg cells are not activated nonspecifically by the inflammatory
milieu of Mtb infection. Expression of each of these molecules
has been associated with enhanced Treg cell immunosuppres-
sion (Chauhan et al., 2009; Miyara and Sakaguchi, 2007; Vignali
et al., 2008; Wing et al., 2008; Zabransky et al., 2012), and this
activation state may explain why small numbers of adoptively
transferred Mtb-specific Treg cells, but not Treg cells with irrele-
vant specificities, were capable of restricting protective immu-1266 Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc.nity against Mtb (Shafiani et al., 2010). T-bet expression by
Mtb-specific Treg cells is likely to be important in their functional
specialization and has been shown to augment their proliferative
and suppressive properties (Koch et al., 2009). In contrast to
reports in Toxoplasma gondii (T. gondii) and neurotropic mouse
hepatitis infections (Oldenhove et al., 2009; Zhao et al., 2011),
Treg cells activated during Mtb infection do not acquire the
ability to produce IFN-g. Thus, inflammation associated with
Mtb infection seems to confer a measured degree of Treg
cell differentiation compared with other infections and results
in an activated but suppressive pathogen-specific Treg cell
population.
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Mtb-Specific Thymically Derived Treg CellsStudies showing that the TCR repertoire of the thymically
derived Treg cell population is at least as diverse as that of con-
ventional CD4+ T cells (Hsieh et al., 2006; Pacholczyk et al.,
2007) may help to explain their capacity to cross react to foreign
antigens despite their positive selection by high-affinity interac-
tions with self-antigens within the thymus (Bautista et al., 2009;
DiPaolo and Shevach, 2009). Our finding that pre-existing thymi-
cally derived Treg cells specific for a pathogen-derived epitope
undergo proliferation in the context of pulmonary infection with
Mtb, but not Lm, suggests that the nature of the inflammatory
environment may dictate whether or not antigen-specific Treg
cells become activated. Despite the fact that IL-6 has been
shown to inhibit Treg cell responses in other experimental sys-
tems (Korn et al., 2007; Pasare and Medzhitov, 2003) and
despite our demonstration that IL-12p40 can drive contraction
of Treg cells in the context of tuberculosis, expansion of Lm-
specific Treg cells was not rescued in mice deficient in either
IL-6 or IL-12p40 (data not shown). Thus, the inflammatory milieu
elicited by Lm probably contains multiple redundant factors that
contribute to the inhibition of Lm-specific Treg cell proliferation.
In the case of Mtb infection, it is tempting to speculate that Mtb
itself manipulates the inflammatory response to promote the
pLN proliferation of these suppressive T cells during the period
of effector T cell priming.
In addition to governing whether antigen-specific Treg cells
expand in numbers, the quality and magnitude of the inflamma-
tory response probably also dictates whether these highly immu-
nosuppressive cells are allowed to persist. Long-term survival of
antigen-specific Treg cells is permitted during the alternative in-
flammatory milieu of pregnancy when their activity is advanta-
geous in promoting fetal tolerance in subsequent pregnancies
(Rowe et al., 2012). By contrast, in the infectious setting of tuber-
culosis, potentially deleterious antigen-specific Treg cells are
actively eliminated. IL-12 and intrinsic T-bet expression within
Mtb-specific Treg cells are each required for their elimination,
suggesting that the culling of immune-suppressive Treg cells is
driven by the Th1 cell inflammatory response. These results
are consistent with recent studies illustrating that intermediate
T-bet expression in Treg cells can be induced by IFN-g and
STAT-1 signaling, but that high expression, such aswe observed
in Mtb-specific Treg cells, requires IL-12 receptor signaling
(Koch et al., 2012). It seems likely that the disappearance of
Mtb-specific Treg cells represents a true contraction, as indi-
cated by the fact that high T-bet expression is proapoptotic in
some settings (Joshi et al., 2007; Oldenhove et al., 2009). How-
ever, future studies are needed to exclude the possibility that
pathogen-specific Treg cells simply turn off Foxp3 expression
and join the Mtb-specific effector T cell pool (Zhou et al., 2009).
In addition to the unambiguous roles of IL-12 and T-bet in
driving antigen-specific Treg cell contraction, the robust expan-
sion of Treg cells at later time points in IL-12p40-deficient mice
suggests that the p40 molecule further restricts the ongoing
proliferation of antigen-specific Treg cells. This restriction of
pathogen-specific Treg cells occurs despite the fact that other
Treg cells in the pLN continue to increase in numbers
(Scott-Browne et al., 2007). The p40 molecule can partner
with p19 to form IL-23 heterodimers, and IL-23 has been
shown to be necessary to sustain Th17 cell responses during
tuberculosis (Khader et al., 2005). In addition, p40 homodimersplay an important role in activating dendritic cells during Mtb
infection and promote migration of Mtb-infected dendritic
cells from the lung to the LDLN (Khader et al., 2006). Further
studies are needed to elucidate the mechanisms by which p40
restricts the expansion of antigen-specific Treg cells during
Mtb infection.
In contrast to the selective culling of pathogen-specific Treg
cells observed during Mtb infection, T. gondii infection, which
elicits an even stronger Th1 cell inflammatory response than
does tuberculosis, drives the collapse of the entire Treg cell
population (Oldenhove et al., 2009). This collapse is driven, at
least in part, by IL-2 deprivation during the extreme Th1 cell envi-
ronment of T. gondii infection and leads to lethal inflammatory
dysregulation. During tuberculosis, however, the global Treg
cell population undergoes continued expansion at the primary
sites of infection in the lungs and pLNs (Kursar et al., 2007;
Scott-Browne et al., 2007) despite the selective culling of path-
ogen-specific Treg cells. Furthermore, Treg cell contraction
during Mtb infection cannot be explained by the lack of IL-2
availability but is driven by intrinsic expression of T-bet within
Mtb-specific Treg cells. Nearly all Treg cells exhibit high T-bet
expression during infection with T. gondii, whereas high expres-
sion of T-bet is restricted almost exclusively to pathogen-spe-
cific Treg cells during Mtb infection. Taken together, our results
suggest that a tempered Th1 cell inflammatory response can
mediate the targeted culling of pathogen-specific Treg cells
without compromising the global Treg cell population and un-
leashing lethal immunopathology.
Although the Mtb-specific Treg cell response that we
observed was short lived, their expansion in the pLN coincides
with the initiation of the effector T cell response at this site
(Cooper, 2009). This is also precisely where and when adoptively
transferred Mtb-specific transgenic Treg cells (fewer than 100
transferred cells in the pLN) were shown to impair protection
by slowing the kinetics of effector T cell priming and arrival in
the lung (Shafiani et al., 2010). Here we report that 150–300
endogenous Treg cells in the pLN are specific for a single Mtb-
derived epitope and that Treg cells recognizing other Mtb anti-
gens also exist. Thus, the relatively high number of endogenous
Mtb-specific Treg cells that accumulate in the pLN is likely to
have a profound effect on the rate at which effector T cells are
primed and reach the lung. This is important because the rapidity
of the effector T cell response to pulmonary Mtb infection is
strongly correlated with long-term protection (Cooper, 2009;
Urdahl et al., 2011). When Mtb effector T cells are late to arrive
in the lung, a prolonged period of unrestrained bacterial replica-
tion ensues and probably contributes to Mtb persistence by
allowing the bacteria to establish a lung niche.
Antigen-specific Treg cells have the capacity to persist as
memory cells when stimulated in the alternative environment of
pregnancy (Rowe et al., 2012). This raises the question of
whether memory Treg cell responses may be induced to myco-
bacteria in less inflammatory scenarios when IL-12p40 levels are
lower or less sustained.Mycobacterium bovisBCG, the tubercu-
losis vaccine currently used, stimulates much less inflammation
compared with Mtb but shares many common antigens (Ander-
sen and Doherty, 2005). Likewise, nontuberculous mycobacteria
that also share many antigens with Mtb are relatively ubiquitous
in the environment (Falkinham, 2009) and human exposure,Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc. 1267
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Mtb-Specific Thymically Derived Treg Cellsusually occurring in the gastrointestinal tract, causes minimal
inflammation. Future studies are needed to determine whether
BCG immunization or exposure to nontuberculousmycobacteria
can induce the expansion of antigen-specific Treg cells, and if
so, whether they are long lived and can mount a recall response
that restricts immunity to Mtb infection.
Our findings have important implications for tuberculosis and
other chronic diseases in which antigen-specific Treg cells
restrict immunity. If the immune pathways that promote anti-
gen-specific Treg cell expansion during early tuberculosis can
be identified, pharmacologic manipulation of these pathways
in recently exposed individuals may provide new avenues to
hasten the protective T cell response, achieve earlier control of
Mtb replication in the lung, and ultimately improve infection
outcomes. Conversely, insights into the IL-12p40-dependent
pathways that mediate the selective culling of antigen-specific
Treg cells during tuberculosis could inform therapeutic strate-
gies for other chronic diseases, such as cancer. Targeted abla-
tion of tumor-specific Treg cells could enhance tumor clearance
with less risk of triggering autoimmunity compared to current
approaches that suppress or eliminate Treg cells nonspecifically
(Byrne et al., 2011).
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, B6.SJL-Ptprca Pepcb/BoyJ (CD45.1), B6.129P2-Tcrbtm1Mom
Tcrdtm1Mom/J (Tcrb/ Tcrd/), B6.129S2-Tcratm1Mom/J (Tcra/), and mice
deficient in IL-6 (B6.129S2-Il6tm1Kopf/J), IL-12p40 (B6.129S1-Il12btm1Jm/J),
IL-12p35 (B6.129S1-Il12atm1Jm/J), and IFN-g (B6.129S7-Ifngtm1Ts/J) were
purchased from Jackson Laboratories. Foxp3-GFP mice (bred 12 times to
C57BL/6 mice) were provided by A. Rudensky (Memorial Sloan-Kettering
Cancer Center, New York, NY), and some of these mice were bred to homozy-
gosity with B6.SJL-Ptprca Pepcb/BoyJ mice (CD45.1). Mice deficient in the
IFN-a/b receptor (Mu¨ller et al., 1994) were provided by A. Aderem (Seattle
Biomedical Research Institute). Mice homozygous for the TCRa gene deletion
were crossed with C57BL/6 mice and the F1 generation (TCRa+/) was used
for Mtb infection. Mice with loxp sites flanking both alleles encoding T-bet
(Tbx21fl/fl) on C57BL/6 background (Intlekofer et al., 2008) were crossed with
Foxp3-IRES-Cre (FIC) transgenic mice on C57BL/6 background (Wing et al.,
2008) to generate Tbx21fl/fl:FIC mice with a specific knockout of Tbx21 in
Foxp3-expressing cells. All mice were housed and bred under specific-path-
ogen-free conditions at the University of Washington and Seattle Biomedical
Research Institute, and all experiments were performed in compliance with
the respective Institutional Animal Care and Use Committees.
Bacteria and Aerosol Infections
A stock of Mtb strain H37Rv was sonicated before use and mice were
infected as described earlier (Shafiani et al., 2010). For Mtb CFU determina-
tion, lungs were homogenized in PBS containing 0.05% Tween 80, and
serial dilutions were plated out on 7H10 agar plates. Colonies were counted
after 21 days of incubation at 37C. In some experiments, mice were
anesthetized with ketamine and xylazine and then intranasally administered
recombinant Listeria monocytogenes engineered to stably express and
secrete Mtb ESAT-61-20 (Lm-ESAT-6; 5 3 10
6 CFUs in 30 ml total volume).
Lm-ESAT-6 was constructed by PCR amplifying the promoter and coding
regions for ESAT-61-20 from the pAM401-based expression construct (Orr
et al., 2007), subcloning into the temperature-sensitive plasmid pKSV7,
and selection for clones with homologous recombination after electropora-
tion into Lm-OVA as described (Rudd et al., 2011). The number of viable
Lm-ESAT-6 in the lungs was performed on a couple of mice 30 min after
infection after plating serial dilutions of the lung homogenate onto BHI agar
and overnight incubation at 37C. In some experiments, an attenuated
strain of Lm lacking the expression of the virulence determinant ActA and1268 Immunity 38, 1261–1270, June 27, 2013 ª2013 Elsevier Inc.expressing the ESAT-6 antigen heterologously was used (1 3 108 CFUs in
50 ml total volume).
Lung and pLN Cell Isolation
Single-cell preparations of lungs and pLNs were prepared as described earlier
(Urdahl et al., 2003). In experiments where IFN-g was being detected directly
ex vivo, brefeldin A (Sigma, 10 mg/ml) was added to all media during tissue
processing.
Tetramer and Surface Staining
PE or APC-labeled MHC class II tetramers (I-Ab) containing the stimulatory
residues 4 to 17 (QQWNFAGIEAAASA) of the early secreted antigenic target
6 kDa (ESAT-6) and amino acids 240 to 254 (FQDAYNAAGGHNAVF) of An-
tigen 85B of Mtb were generous gifts from M. Jenkins (Moon et al., 2007)
and the NIH tetramer facility, respectively. APC-labeled MHC class II tetra-
mers (I-Ab) containing the stimulatory residues 190 to 201 (NEKYAQAYPNVS)
of the Listeriolysin (LLO) antigen of Listeria monocytogenes was kindly
provided by M. Pepper. Single-cell preparations from lungs and pLNs were
incubated for 1 hr at room temperature with tetramers (5–10 nM) in 1:1 Fc
block (2.4G2) and sorter buffer (PBS containing 0.1% NaN3 and 2.5%
fetal bovine serum), followed by washing in sorter buffer. Lung cells were
then stained with anti-CD3 (eBioscience), anti-CD4 (Invitrogen), anti-CD44
(eBioscience), anti-CD8 (eBioscience), and a non-T cell cocktail containing
anti-F4/80, anti-CD19, anti-CD11c, and anti-CD11b (eBioscience). ESAT-
64-17 or Ag85B240-254-specific T cells were identified as CD3
+, non-T cell
cocktail-negative, CD4+, CD8, tetramer+, CD44hi events. Because of the
lower frequency of antigen-specific T cells in the lymph nodes, after the
tetramer staining step, the pLNs were enriched for antigen-specific cells as
described earlier (Moon et al., 2009) and stained for surface markers, as
described for lungs. Additionally, in some experiments, antibodies were
used to detect CD25 (BD Biosciences), GITR (BD Biosciences), CD103 (BD
Biosciences), ICOS (BD Biosciences), Vb6 TCR (BD Biosciences), CD45.1
(eBioscience), and CD45.2 (eBioscience) markers. Samples were fixed
and analyzed with a FACSCanto or LSR-II (BD Biosciences) and FlowJo
(Treestar) software.
Intracellular Staining
In most experiments, tetramer and surface staining was followed by staining
for intracellular markers according to manufacturer’s recommendations
(eBioscience). Cells were fixed and permeabilized with eBiosciences Fix/
Perm buffer for 1 hr, followed by staining for Foxp3 by Foxp3 antibodies
(eBioscience) in Permeabilization/Wash buffer (eBiosciences) for 30 min.
Stained cells were acquired and analyzed as described above. In some exper-
iments, IFN-g (BD Biosciences), Helios (Biolegend), CTLA-4 (BD Biosciences),
and T-bet (Biolegend) antibodies were added in addition to Foxp3 to allow the
detection of these markers.
Adoptive Transfer
For adoptive transfer experiments, CD4+ T cells from Foxp3-GFP reporter
mice on congenic CD45.1 and CD45.2 backgrounds were negatively enriched
to >95% purity from freshly isolated spleen and LN cells, using magnetic
microbeads and subsequent column purification according to the manufac-
turer’s protocol (Miltenyi Biotec). GFP+ cells (Treg cells) and GFP cells
(conventional CD4+ T cells) were then sorted from the CD45.1- and CD45.2-
expressing populations, respectively, on a FACSAria (BD Biosciences). Sorted
cells were then analyzed for purity, mixed, and adoptively cotransferred into
recipient TCRb/TCRd/ mice (1.5 3 106 GFP+ and 10 3 106 Foxp3-GFP
cells per mouse).
IL-2-Anti-IL-2 Antibody Complex Treatment
IL-2 cytokine and anti-IL-2 antibody were purchased from eBioscience and
Bio X Cell, respectively. Starting on day 20 after Mtb infection, mice received
daily intraperitoneal doses of amixture of IL-2 (1.5 mg) and IL-2 antibody (15 mg)
per mouse (200 ml volume) for 5 consecutive days before being harvested on
day 25 after infection. Prior to injection, the IL-2 cytokine and IL-2 antibody
were mixed and incubated at 37C for 30min. Control mice were administered
equal volume of PBS.
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